2,006
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Successful Treatment of Hypersplenism in Wilson's Disease by Partial Splenic Embolization

, , , &
Pages 75-81 | Received 17 Nov 2016, Accepted 27 Dec 2016, Published online: 31 Jan 2017

References

  • Loudianos G, et al. Wilson's disease. Prilozi 2014;35(1):93–98.
  • Pfeiffer RF. Wilson's Disease. Semin Neurol. 2007;27(2): 123–132.
  • Harada M. Pathogenesis and management of Wilson disease. Hepatol Res. 2014.
  • Brewer GJ. Novel therapeutic approaches to the treatment of Wilson's disease. Expert Opin Pharmacother. 2006;7(3):317–324.
  • Amin MA, et al. Partial splenic embolization versus splenectomy for the management of hypersplenism in cirrhotic patients. World J Surg. 2009;33(8):1702–1710.
  • Zhu K et al. Partial splenic embolization for hypersplenism in cirrhosis: A long-term outcome in 62 patients. Dig Liver Dis. 2009;41(6):411–416.
  • Sternlieb I, Scheinberg IH, and Walshe JM. Bleeding oesophageal varices in patients with Wilson's disease. Lancet 1970;1(7648):638–641.
  • Abdella HM, et al. Role of partial splenic arterial embolization for hypersplenism in patients with liver cirrhosis and thrombocytopenia. Indian J Gastroenterol. 2010;29(2):59–61.
  • Alzen G, et al. Partial splenic embolization as an alternative to splenectomy in hypersplenism–single center experience in 16 years. Klin Padiatr. 2010;222(6):368–373.
  • Yoshida H, et al. Partial splenic embolization. Hepatol Res. 2008;38(3):225–233.
  • Madoff DC, et al. Splenic arterial interventions: Anatomy, indications, technical considerations, and potential complications. Radiographics 2005;25(Suppl 1):S191–S211.
  • Koconis KG, Singh H, and Soares G. Partial splenic embolization in the treatment of patients with portal hypertension: A review of the English language literature. J Vasc Interv Radiol. 2007;18(4):463–481.
  • Murata K, et al. Splenectomy improves liver function in patients with liver cirrhosis. Hepatogastroenterology 2008;55(85):1407–1411.
  • Smith M, Ray C.E. Splenic artery embolization as an adjunctive procedure for portal hypertension. Semin Intervent Radiol. 2012;29(2):135–139.
  • Tokgoz O, et al. Infraclavicular brachial plexus block in Wilson's disease. Middle East J Anesthesiol. 2013;22(1):103–106.
  • Baykal M, Karapolat S. Anesthetic management of a pediatric patient with wilsons disease. J Clin Med Res. 2010;2(2):99–101.
  • Bo W, et al. Laparoscopy splenectomy for massive splenomegaly. J Invest Surg. 2013;26(3):154–157.
  • Gu JJ, et al. Safety and efficacy of splenic artery coil embolization for hypersplenism in liver cirrhosis. Acta Radiol. 2012;53(8):862–867.
  • Kim B, Chung SJ, and Shin HW. Trientine-induced neurological deterioration in a patient with Wilson's disease. J Clin Neurosci. 2013;20(4):606–608.
  • Kim YE, et al. Unusual epileptic deterioration and extensive white matter lesion during treatment in Wilson's disease. BMC Neurol. 2013;13:127.
  • Kalita J, et al. Worsening of Wilson disease following penicillamine therapy. Eur Neurol. 2014;71(3,4):126–31.
  • Lang CJ, et al. Fatal deterioration of Wilson's disease after institution of oral zinc therapy. Arch Neurol. 1993;50(10):1007–1008.
  • Choi BS, Zheng W. Copper transport to the brain by the blood-brain barrier and blood-CSF barrier. Brain Res. 2009;1248:14–21.
  • Monnot AD, et al. Regulation of brain copper homeostasis by the brain barrier systems: effects of Fe-overload and Fe-deficiency. Toxicol Appl Pharmacol. 2011;256(3): 249–257.
  • Stuerenburg HJ. CSF copper concentrations, blood-brain barrier function, and coeruloplasmin synthesis during the treatment of Wilson's disease. J Neural Transm. 2000;107(3):321–329.
  • Li WJ, Wang JF, Wang XP. Wilson's disease: update on integrated Chinese and Western medicine. Chin J Integr Med. 2013;19(3): 233–240.
  • Aggarwal A, Bhatt M. Update on Wilson disease. Int Rev Neurobiol. 2013;110:313–348.
  • Dalvi A, Padmanaban M. Wilson's disease: etiology, diagnosis, and treatment. Dis Mon. 2014;60(9):450–459.